Applied Therapeutics, Inc. — Director's Dealing 2023

Dec 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2023-11-30

Reporting Person: Shendelman Shoshana (Director, President and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-30	Common Stock	S	3968	$1.97	Disposed	2596387	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1750000	Indirect
Common Stock	1492094	Indirect
Common Stock	709720	Indirect
Common Stock	290280	Indirect
Common Stock	88397	Indirect

Footnotes

F1: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.

F2: Through a grantor retained annuity trust.

F3: Through a family trust controlled by the reporting person's spouse.

F4: Through the reporting person's spouse.

F5: Through a family trust controlled by the reporting person.

F6: Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.